MARKSANSNSEMarksans Pharma Limited· PharmaceuticalsLowNeutral
Announced Mon, 25 May · 17:44 IST

Marksans Pharma Limited has informed the Exchange regarding Grant of 300000 Options under Marksans Employee Stock Option Scheme 2024

MARKSANS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+12.7%1-day move
₹220.50
prior close
₹221.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.1-1.3-1.3-0.7+12.7+11.5+9.8+9.8+10.2+5.9+15.6+19.8+19.8
Up moveDown movePending
AI summary

Marksans Pharma has granted 3,00,000 stock options to eligible employees under its Employees Stock Option Scheme 2024. The grant date is May 25, 2026. Each option allows employees to acquire one equity share of face value Re. 1/- at an exercise price of Rs. 10 per option. The scheme complies with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and was approved by shareholders at AGMs held in September 2024 and August 2025. Options vest after 1 year from grant date, and once vested, can be exercised within 2 years.

Likely market impact

The ESOP grant aligns employee interests with shareholders but will cause minor share dilution when exercised. The low exercise price of Rs. 10 indicates significant value transfer to employees.